familymednews.com
Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis. And standard treatment for the condition includes 7 weeks of radiation, often along with chemotherapy. “We put patients through toxic treatment for seven weeks when most will only live five months. I’m not sure that’s how I would want to spend my time,” […]
Continue reading »
Migraine sufferers on Thursday got some relief from US regulators who approved the first of a new class of drugs for migraine prevention. The United States Food and Drug Administration said it endorsed Aimovig for prevention of migraine in adults, through monthly self-injections. Aimovig is the first in a new class of drugs that work by blocking the activity of […]
Continue reading »
Structural biologists at St. Jude Children’s Research Hospital have discovered how a key protein functions to trigger cell’s suicide machinery, called apoptosis. The scientists found that the protein, called BOK, is controlled separately from the rest of the apoptosis process—offering the potential for new drugs to more selectively kill cancer cells. Led by Tudor Moldoveanu, Ph.D., an assistant member of […]
Continue reading »
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving […]
Continue reading »
(HealthDay)—Millions of U.S. seniors can now take part in a Medicare program designed to prevent prediabetes from progressing to type 2 diabetes. Almost half of Americans 65 and older have prediabetes, and many don’t know it. In addition to an increased risk of type 2 diabetes, prediabetes puts people at risk of heart disease and stroke, according to the American […]
Continue reading »
The multi-target small molecule anticancer drug nintedanib shows promising effectiveness in stopping the growth of human malignant pleural mesothelioma, a fatal thoracic tumor, in preclinical models, according to a new study published jointly by researchers in Austria, Germany and Hungary. Malignant pleural mesothelioma is a particularly aggressive tumor that occurs in the lining that covers the lungs. It typically results […]
Continue reading »
When we view natural images the colours we perceive are due to colour information at every local patch of an image, rather than how colours interact when they transition from one point to another, according to a new study from researchers at City, University of London. The finding supports the role that colour processing cells in the brain play when […]
Continue reading »
Khloé Kardashian is getting her gym groove back! The Keeping Up with the Kardashians star used Snapchat Thursday to document her feelings following a post-pregnancy workout with her trainer — her first since giving birth to daughter True on April 12. Kardashian, 33, admitted to her followers that while she was “exhausted” following the sweat session, she was feeling positive and strong […]
Continue reading »
Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs. The research team from the Departments of Pharmacy & Pharmacology and Chemistry are studying a protein called α-methylacyl-CoA racemase (AMACR) as a potential […]
Continue reading »
Schizophrenia is considered a disorder of the mind, influencing the way a person thinks, feels and behaves. But our latest research shows that organs, other than the brain, also change at the onset of the disease. Scientists have known for a long time that people with schizophrenia have much higher rates of physical illness compared with the general population, and […]
Continue reading »